Gefapixant Citrate, a Selective P2X3 Receptor Antagonist, May Improve Cancer-Related Hypergeusia: A Case Report.
Saved in:
| Title: | Gefapixant Citrate, a Selective P2X3 Receptor Antagonist, May Improve Cancer-Related Hypergeusia: A Case Report. |
|---|---|
| Authors: | Murakami S; Department of Palliative Medicine, Seirei Sakura Citizen Hospital, Chiba, Japan., Yamagishi K; Department of Respiratory Medicine, Seirei Sakura Citizen Hospital, Chiba, Japan., Kitani A; Department of Breast Surgery, Seirei Sakura Citizen Hospital, Chiba, Japan., Ueta T; Department of Department of Orthopedic Surgery, Seirei Sakura Citizen Hospital, Chiba, Japan., Matsuura Y; Department of Palliative Medicine, Seirei Sakura Citizen Hospital, Chiba, Japan., Kubota T; Department of Palliative Medicine, Seirei Sakura Citizen Hospital, Chiba, Japan., Uezono Y; Department of Pain Control Research, The Jikei University School of Medicine, Tokyo, Japan. |
| Source: | Journal of palliative medicine [J Palliat Med] 2026 Apr; Vol. 29 (4), pp. 557-561. Date of Electronic Publication: 2025 Oct 07. |
| Publication Type: | Journal Article; Case Reports |
| Journal Info: | Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9808462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-7740 (Electronic) Linking ISSN: 15577740 NLM ISO Abbreviation: J Palliat Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1557-7740 |
|---|---|
| DOI: | 10.1177/10966218251385732 |
